Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.

Changing the way antibiotics are developed and accessed.

A public-health driven model to tackle AMR.

Our latest news and resources.

Protecting people from the rise and spread of drug-resistant infections.

Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.

Media coverage.

Filter by

India Today (700 x 430 px)
Neonatal sepsis

Indian newborns join global race to beat deadly drug-resistant sepsis

Read full story
Nature India (700 x 430 px)
Neonatal sepsis

Researchers seek better antibiotics for newborn sepsis amid rising drug resistance

Read full story
Project Syndicate logo
Corporate

Global Health Reform Must Bolster Innovation

Read full story
Geneva solutions Thumbnail
Corporate

‘It’s possible to have a collective success’: three Geneva health non-profits bolster ties amid shrinking aid

Read full story
Modern Ghana logo (1)
Neonatal sepsis

A meaningful step forward in newborn health in Ghana

Read full story
Medical Tribune Thumbnail
Sexually transmitted infections

淋病の新規抗菌薬承認で「治療の転換期」へ

Read full story
CIDRAP media coverage thumbnail
Sexually transmitted infections

GARDP, Debiopharm to collaborate on new gonorrhea antibiotic

Read full story
Nikkei Thumbnail
Sexually transmitted infections

りん病の新たな抗菌薬、数十年ぶりに承認　世界初の飲み薬

Read full story
Nuzolvence MediaCoverage Thumbnail
Sexually transmitted infections

US FDA approval of Nuzolvence® (zoliflodacin), a first-in-class antibiotic for gonorrhoea

Read full story